Vanda Alice Lennon
#101,043
Most Influential Person Now
Vanda Alice Lennon's AcademicInfluence.com Rankings
Vanda Alice Lennonbiology Degrees
Biology
#5052
World Rank
#7439
Historical Rank
Immunology
#222
World Rank
#231
Historical Rank

Download Badge
Biology
Vanda Alice Lennon's Degrees
- PhD Immunology University of California, San Francisco
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Vanda Alice Lennon Influential?
(Suggest an Edit or Addition)Vanda Alice Lennon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (2002) (2964)
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis (2004) (2780)
- Revised diagnostic criteria for neuromyelitis optica (2006) (2511)
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel (2005) (2026)
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (2002) (1995)
- The spectrum of neuromyelitis optica (2007) (1939)
- Brain abnormalities in neuromyelitis optica. (2006) (681)
- Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. (2007) (672)
- Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. (2006) (669)
- Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. (2000) (601)
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis (2006) (555)
- Neuromyelitis optica and non organ-specific autoimmunity. (2008) (555)
- Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. (1995) (547)
- Antibody to acetylcholine receptor in myasthenia gravis (1976) (522)
- CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity (2001) (501)
- Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies (1998) (478)
- Steroid-responsive encephalopathy associated with autoimmune thyroiditis. (2006) (456)
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica (2007) (436)
- Postural orthostatic tachycardia syndrome: the Mayo clinic experience. (2007) (421)
- Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. (1999) (408)
- Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody (2004) (398)
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis (2018) (384)
- Autoimmune epilepsy: clinical characteristics and response to immunotherapy. (2012) (327)
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study (2013) (317)
- Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. (1994) (313)
- NMO-IgG predicts the outcome of recurrent optic neuritis (2008) (312)
- Serologic diagnosis of NMO (2012) (310)
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 (2008) (301)
- Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome (2004) (300)
- Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs (1975) (300)
- Antibody to acetylcholine receptor in myasthenia gravis (1976) (300)
- Amphiphysin autoimmunity: Paraneoplastic accompaniments (2005) (294)
- Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. (2016) (290)
- A secondary progressive clinical course is uncommon in neuromyelitis optica (2007) (286)
- Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients (2017) (283)
- CNS aquaporin-4 autoimmunity in children (2008) (279)
- Neuromyelitis optica unique area postrema lesions (2011) (277)
- Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes (2011) (265)
- Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments (2003) (262)
- Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders (2008) (257)
- EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS AND MYASTHENIA GRAVIS: BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS * (1976) (252)
- Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. (2003) (251)
- Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis (1978) (239)
- Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model (1977) (235)
- Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrum (2016) (234)
- Immunoglobulins promote remyelination in the central nervous system (1990) (225)
- Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders (2018) (224)
- Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. (2018) (215)
- Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer‐related syndromes (1998) (213)
- Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies (1976) (212)
- Stiff-man syndrome and variants: clinical course, treatments, and outcomes. (2012) (209)
- Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis a (1987) (209)
- Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. (2006) (207)
- Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity (2001) (205)
- Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. (2015) (198)
- Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica (2013) (196)
- Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors (1980) (194)
- Autoantibody Profiles and Neurological Correlations of Thymoma (2004) (194)
- Expanded phenotypes and outcomes among 256 LGI1/CASPR2‐IgG–positive patients (2017) (194)
- The spectrum of autoimmune autonomic neuropathies (2003) (192)
- Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG (2003) (189)
- Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma (2002) (186)
- Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus (1994) (184)
- Aquaporin-4 autoantibodies in a paraneoplastic context. (2008) (183)
- Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy (2014) (181)
- Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. (2013) (180)
- Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value (1998) (179)
- Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. (2013) (176)
- EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS: CELLULAR AND HUMORAL IMMUNE RESPONSES * (1976) (175)
- Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. (2008) (173)
- Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. (1991) (173)
- Beneficial plasma exchange response in central nervous system inflammatory demyelination. (2011) (172)
- New Purkinje cell antibody (PCA‐2): Marker of lung cancer–related neurological autoimmunity (2000) (171)
- Clinical spectrum of voltage-gated potassium channel autoimmunity (2008) (171)
- Intractable vomiting as the initial presentation of neuromyelitis optica (2010) (170)
- Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis (1976) (169)
- Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders (2009) (168)
- Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. (2015) (167)
- Identification of Three Subunits of the High Affinity ω-Conotoxin MVIIC-sensitive Ca2+ Channel* (1996) (166)
- Aquaporin-4 autoimmunity (2015) (163)
- ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity (2001) (157)
- Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics (2001) (156)
- Autoimmune dementia: clinical course and predictors of immunotherapy response. (2010) (155)
- Chronic pain as a manifestation of potassium channel-complex autoimmunity (2012) (154)
- THE MOTOR END PLATE IN MYASTHENIA GRAVIS AND IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS. A QUANTITATIVE ULTRASTRUCTURAL STUDY * (1976) (154)
- Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. (2009) (150)
- Subunit Heterogeneity in N-type Ca Channels (*) (1996) (150)
- Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. (2003) (150)
- DPPX potassium channel antibody (2014) (149)
- Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability (2002) (131)
- Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro (2016) (128)
- Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. (1990) (128)
- Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica (2009) (127)
- Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis (2009) (122)
- Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin (1986) (122)
- Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. (1998) (119)
- Remyelination by Oligodendrocytes Stimulated by Antiserum to Spinal Cord (1987) (118)
- Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. (2019) (117)
- Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. (1990) (117)
- Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. (2010) (114)
- Passive Transfer of Autoimmune Autonomic Neuropathy to Mice (2004) (113)
- ULTRASTRUCTURAL LOCALIZATION OF IMMUNE COMPLEXES (IgG and C3) AT THE END‐PLATE IN EXPERIMENTAL AUTOMMUNE MYASTHENIA GRAVIS (1977) (112)
- END‐PLATE POTENTIALS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IN RATS * (1976) (111)
- Paraneoplastic isolated myelopathy (2011) (111)
- Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. (1989) (110)
- Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. (2009) (108)
- GABAB receptor autoantibody frequency in service serologic evaluation (2013) (108)
- Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. (1991) (108)
- MONOCLONAL AUTOANTIBODIES TO ACETYLCHOLINE RECEPTORS: EVIDENCE FOR A DOMINANT IDIORPE AND REQUIREMENT OF COMPLEMENT FOR PATHOGENICITY * (1981) (107)
- Absence of cortical demyelination in neuromyelitis optica (2010) (105)
- Sleep manifestations of voltage-gated potassium channel complex autoimmunity. (2011) (101)
- Predictive models in the diagnosis and treatment of autoimmune epilepsy (2017) (99)
- Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica (2017) (99)
- Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome (1997) (98)
- Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. (1985) (97)
- Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder (2020) (94)
- Frequency of seronegativity in adult‐acquired generalized myasthenia gravis (2007) (94)
- Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year (2018) (94)
- Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. (1991) (93)
- EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS: A SEQUENTIAL AND QUANTITATIVE STUDY OF THE NEUROMUSCULAR JUNCTION ULTRASTRUCTURE AND ELECTROPHYSIOLOGIC CORRELATIONS (1976) (92)
- Myasthenia gravis with autoimmune autonomic neuropathy (2001) (91)
- Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. (2009) (90)
- STIFF-PERSON SYNDROME WITH AMPHIPHYSIN ANTIBODIES: DISTINCTIVE FEATURES OF A RARE DISEASE (2009) (90)
- Effects of age and sex on aquaporin-4 autoimmunity. (2012) (90)
- The case for a descriptive generic nomenclature (1994) (89)
- Passively transferred experimental autoimmune myasthenia gravis (1979) (89)
- Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. (2004) (89)
- OSMS is NMO, but not MS: proven clinically and pathologically (2006) (88)
- Autoimmunity in the Lambert-Eaton myasthenic syndrome. (1982) (88)
- Appearance of neurons in the developing chick gut (1995) (88)
- Autoimmune chorea in adults (2013) (87)
- Immunoglobulins reactive with myelin basic protein promote CNS remyelination (1996) (87)
- Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. (2008) (87)
- NMO-IgG: A Specific Biomarker for Neuromyelitis Optica (2006) (84)
- Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study (2014) (84)
- Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. (2006) (83)
- IgLON5 antibody (2017) (83)
- Neurological autoimmunity targeting aquaporin-4 (2010) (83)
- Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome (1998) (81)
- Lambert‐eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small‐cell lung carcinoma (1996) (78)
- Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. (1992) (78)
- Genetic control of experimental autoimmune myasthenia gravis in mice. I. Lymphocyte proliferative response to acetylcholine receptors is under H-2-linked Ir gene control. (1979) (77)
- Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. (2018) (76)
- Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. (2011) (76)
- P/Q‐ and N‐type calcium‐channel antibodies: Oncological, neurological, and serological accompaniments (2016) (75)
- Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). (2010) (75)
- CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG (2011) (75)
- Clinical utility of testing AQP4-IgG in CSF (2016) (74)
- Neural antigen‐specific autoimmune disorders (2012) (73)
- Immunopharmacological disease: a break in tolerance to receptor sites. (1971) (73)
- Experimental autoimmune autonomic neuropathy. (2003) (73)
- Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine. (1988) (71)
- Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin. (1970) (69)
- AQP4 autoantibody assay performance in clinical laboratory service (2014) (68)
- Transitory expression of Thy-1 antigen in skeletal muscle development (1977) (66)
- Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. (2020) (65)
- Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease. (1999) (64)
- End‐plate voltage‐gated sodium channels are lost in clinical and experimental myasthenia gravis (1998) (64)
- The laboratory diagnosis of mild myasthenia gravis (1982) (63)
- IMMUNOTHERAPY-RESPONSIVE DEMENTIAS AND ENCEPHALOPATHIES (2010) (63)
- Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. (2013) (63)
- Neural Autoantibody Profile of Primary Achalasia (2010) (62)
- Selected IgG rapidly induces Lambert–Eaton myasthenic syndrome in mice: Complement independence and EMG abnormalities (1988) (62)
- Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. (2014) (61)
- Childhood onset of stiff-man syndrome. (2013) (61)
- Autoimmune myelopathy associated with collapsin response‐mediator protein‐5 immunoglobulin G (2008) (60)
- Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases (2018) (59)
- GENETIC CONTROL OF AUTOIMMUNITY TO ACETYLCHOLINE RECEPTORS: ROLE OF Ia MOLECULES * (1981) (59)
- Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis. (2014) (59)
- Autoimmune paraneoplastic cerebellar degeneration (1988) (58)
- The neurologic significance of celiac disease biomarkers (2014) (58)
- Paraneoplastic autoantibodies (1994) (57)
- Neuronal voltage-gated potassium channel complex autoimmunity in children. (2011) (57)
- Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis (1989) (56)
- Neurectoderm markers retained in phenotypical skeletal muscle cells arising from a glial cell line (1979) (56)
- Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. (2020) (55)
- Brain-derived fibroblast growth factor: identity with a fragment of the basic protein of myelin. (1978) (54)
- Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies (1998) (54)
- Paraneoplastic dysmotility: loss of interstitial cells of Cajal (2002) (53)
- Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction (2018) (52)
- N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. (2011) (52)
- Intractable nausea and vomiting from autoantibodies against a brain water channel. (2013) (52)
- Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes (1988) (52)
- Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. (1991) (51)
- Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. (1988) (51)
- Identification and Cloning of Putative Human Neuronal Voltage-Gated Calcium Channel γ-2 and γ-3 Subunits: Neurologic Implications (1999) (51)
- Neural Autoantibody Clusters Aid Diagnosis of Cancer (2014) (50)
- Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. (2014) (50)
- Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility (2014) (50)
- An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study (2010) (49)
- Microtubule‐associated protein 1B: Novel paraneoplastic biomarker (2017) (49)
- Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors. (1982) (49)
- Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. (2014) (48)
- Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma. (2016) (48)
- Optic Neuritis In the Era of Biomarkers. (2019) (47)
- The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions (1984) (47)
- Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica (2017) (47)
- Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica (2011) (46)
- Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions (2015) (46)
- Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. (2016) (46)
- Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. (2020) (46)
- How myasthenia gravis alters the safety factor for neuromuscular transmission (2008) (45)
- Nicotinic Acetylcholine Receptors of Muscle and Neuronal (α7) Types Coexpressed in a Small Cell Lung Carcinoma (1997) (45)
- Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. (2015) (45)
- Congenital myasthenia gravis in 13 smooth fox terriers. (1983) (45)
- Detection of antibodies to the basic protein of human myelin by radioimmunoassay and immunofluorescence. (1971) (44)
- Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient (2013) (44)
- LGI1 and CASPR2 neurological autoimmunity in children (2018) (44)
- Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders. (1989) (43)
- Acetylcholine Receptors in Small Cell Carcinomas (1985) (43)
- Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. (2010) (43)
- Demyelination and Remyelination in Murine Viral Encephalomyelitis a (1984) (43)
- Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. (2011) (42)
- EXPERIMENTAL AUTOIMMUNE MYASTHENIA: CLINICAL, NEUROPHYSIOLOGIC, AND PHARMACOLOGIC ASPECTS * (1976) (42)
- Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. (1990) (41)
- Thy-1: a differentiation marker of potential mammary myoepithelial cells in vitro. (1978) (41)
- Calcium Channel and Related Paraneoplastic Disease Autoantibodies (1996) (40)
- Clinical utility of testing AQP 4-IgG in CSF Guidance for physicians (40)
- Muscle specific kinase autoimmune myasthenia gravis in children: A case series (2013) (40)
- Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. (1992) (39)
- Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy. (2019) (39)
- Whole-body tremulousness: isolated generalized polymyoclonus. (2007) (38)
- Purification and biochemical characterization of nicotinic acetylcholine receptors of human muscle. (1982) (38)
- Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cells. (1979) (38)
- Striational antibodies in a paraneoplastic context (2013) (37)
- Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability (1999) (37)
- Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders (2018) (37)
- Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor (2017) (37)
- Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG (2003) (36)
- Role of T lymphocytes in the pathogenesis of experimental autoimmune encephalomyelitis (1973) (36)
- Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis. (1990) (36)
- Paraneoplastic neuronal intermediate filament autoimmunity (2018) (36)
- Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. (2000) (35)
- Immunology of the acetylcholine receptor. (1976) (35)
- Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. (1991) (35)
- Binding of 125 I myelin basic protein by serum and cerebrospinal fluid. (1972) (34)
- Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. (2009) (34)
- Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. (1988) (34)
- Peripherin-IgG association with neurologic and endocrine autoimmunity. (2010) (34)
- Activation of M3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. (1990) (33)
- Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. (1988) (33)
- Autoantibodies to acetylcholine receptors in myasthenia gravis. (1983) (33)
- Paraneoplastic movement disorder in a patient with non‐Hodgkin's lymphoma and CRMP‐5 autoantibody (2003) (33)
- α‐Bungarotoxin Binds to Human Acetylcholine Receptor α‐Subunit Peptide 185–199 in Solution and Solid Phase but Not to Peptides 125–147 and 389–409 (1990) (32)
- Evidence of aquaporin involvement in human central pontine myelinolysis (2013) (32)
- Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments (2019) (32)
- Myasthenia gravis in the cat. (1988) (32)
- Binding of encephalitogenic basic protein by serum alpha-globulins. (1970) (32)
- Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG (2019) (31)
- Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis (2011) (31)
- The immunopathology of myasthenia gravis. (1978) (31)
- Myasthenia gravis in two cats. (1983) (31)
- Reduced muscle acetylcholine sensitivity in rats immunised with acetylcholine receptor (1976) (30)
- Seronegativity for type 1 antineuronal nuclear antibodies ('anti‐Hu') in subacute sensory neuronopathy patients without cancer (1993) (30)
- Enteric GABA‐containing nerves projecting to the guinea‐pig inferior mesenteric ganglion modulate acetylcholine release. (1993) (29)
- Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma. (1992) (29)
- Elevated LGI1‐IgG CSF index predicts worse neurological outcome (2018) (28)
- Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine (2002) 8 (793-800)) (2002) (28)
- Autoimmune septin-5 cerebellar ataxia (2018) (28)
- The complement C3‐C3aR pathway mediates microglia–astrocyte interaction following status epilepticus (2020) (28)
- Endoplasmic Reticulum Membrane-sorting Protein of Lymphocytes (BAP31) Is Highly Expressed in Neurons and Discrete Endocrine Cells (2001) (28)
- Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. (2011) (28)
- Paraneoplastic dysmotility: loss of interstitial cells of Cajal. (2002) (27)
- Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. (2002) (27)
- Myasthenogenicity of human acetylcholine receptor synthetic alpha-subunit peptide 125-147 does not require intramolecular disulfide cyclization. (1987) (26)
- Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis (1976) (26)
- Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. (2009) (26)
- Neurologic autoimmunity and immune checkpoint inhibitors (2020) (26)
- Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter (2003) (26)
- Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. (2001) (25)
- Properties of nicotinic acetylcholine receptors isolated by affinity chromatography on monoclonal antibodies. (1980) (25)
- Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel—loss-of-function cellular model of SCA6 (2004) (25)
- Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review. (2003) (25)
- Intestinal pseudo‐obstruction, type 1 anti‐neuronal nuclear antibodies and small‐cell carcinoma of the lung (1993) (24)
- Neuronal Ganglionic Acetylcholine Receptor Autoimmunity (2003) (24)
- Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol (2012) (23)
- Morphological characteristics and immunohistochemical detection of nicotinic acetylcholine receptors on intestinofugal afferent neurones in guinea‐pig colon (2003) (23)
- Selective Complexing of Acetylcholinesterase in Brain by Intravenously Administered Monoclonal Antibody (1990) (23)
- Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies (1993) (22)
- Eliminating false‐positive results in serum tests for neuromuscular autoimmunity (2010) (22)
- Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy (1999) (22)
- Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire (1992) (22)
- Hydrocephalus in neuromyelitis optica (2014) (22)
- Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors (1975) (21)
- ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association (2017) (21)
- Exchange transfusion in neonatal myasthenia gravis (1981) (21)
- STIFF EYES IN STIFF-PERSON SYNDROME (2008) (21)
- Acetylcholine receptor autoantibody secretion by thymocytes: Relationship to myasthenia gravis (1997) (21)
- Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity (2015) (20)
- Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain. (1985) (20)
- Myasthenia Gravis and Related Disorders: Experimental and Clinical Aspects (1993) (19)
- Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors (1984) (19)
- Absence of Brain Antibodies in Senile Dementia (1970) (18)
- Immunofluorescence Analysis of Surface Acetylcholine Receptors on Muscle: Modulation by Auto-Antibodies (1978) (18)
- Comment on “Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2” (2014) (18)
- Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes (2008) (18)
- Differentiation of skeletal muscle from dissociated optic nerve cells Immunocytochemical observations (1981) (18)
- Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: neurologic implications. (1999) (18)
- GABAA receptor autoimmunity (2019) (18)
- Thy-1 antigen expression on rat brain cell lines (1978) (17)
- Neurochondrin neurological autoimmunity (2019) (17)
- Glucocorticoids Target Ependymal Glia and Inhibit Repair of the Injured Spinal Cord (2019) (16)
- Clinical‐pathologic correlations in voltage‐gated Kv1 potassium channel complex‐subtyped autoimmune painful polyneuropathy (2017) (16)
- Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy (2014) (16)
- Lymphocytes binding basic protein of myelin; cytophilic serum antibody and effect of adjuvant. (1973) (15)
- Tests for pernicious anemia: serum intrinsic factor blocking antibody. (1983) (15)
- Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations (2021) (15)
- Hyperacute autoimmune encephalomyelitis induced by a synthetic autoantigen (1977) (15)
- Autoimmune form of myasthenia gravis in a juvenile Yorkshire Terrier x Jack Russell Terrier hybrid contrasted with congenital (non-autoimmune) myasthenia gravis of the Jack Russell. (1980) (14)
- Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity. (2003) (14)
- An avidin-biotin-peroxidase assay to detect synthetic peptides bound to polystyrene plates. (1991) (14)
- Serum Antibodies and Monoclonal Antibodies Secreted by Thymic B‐Cell Clones from Patients with Myasthenia Gravis Define Striational Antigens a (1987) (14)
- Definition of Myasthenogenic Sites of the Human Acetylcholine Receptor Using Synthetic Peptides a (1987) (14)
- Neuromuscular transmission in nude mice bearing oat cell tumors from Lambert-Eaton myasthenic syndrome. (1982) (13)
- Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker (2021) (13)
- NMDAR encephalitis: which specimens, and the value of values (2014) (13)
- Immunological responses of guinea pigs to a synthetic autoantigen of brain (1974) (13)
- Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma. (1997) (13)
- Neural Autoantibody Evaluation in Functional Gastrointestinal Disorders: A Population-Based Case–Control Study (2011) (12)
- Identification of three extended antibody-binding segments in recombinant human muscle acetylcholine receptor alpha subunit extracellular domain 1-210. (1991) (12)
- A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. (1997) (12)
- Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism (1984) (12)
- Humoral and cell-mediated immune responses of Lewis rats to syngeneic basic protein of myelin. (1974) (12)
- Guamanian neurodegenerative disease (1997) (12)
- Paraneoplastic cerebellar autoantibodies associated with gynecological cancer bind to myenteric plexus neurons (1991) (11)
- Mouse T lymphocyte response to acetylcholine receptor determined by T cell receptor for antigen V beta gene products recognizing Mls-1a. (1991) (11)
- Stability of bombesin in serum, plasma, urine, and culture media. (1985) (11)
- A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers (2015) (11)
- Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding (1992) (11)
- Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitreitis, and Optic Disc Edema. (2020) (10)
- Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo") (1998) (10)
- Myasthenia gravis: diagnosis by assay of serum antibodies. (1982) (10)
- Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice (2013) (10)
- Do calcium channel autoantibodies cause cerebellar ataxia with Lambert–Eaton syndrome? (2003) (10)
- Radiation treatment for thymoma in a dog. (1987) (10)
- Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. (2020) (10)
- The Prevalence of Electrophysiological and Immunological Abnormalities in Asymptomatic Relatives of Patients with Myasthenia Gravis a (1987) (10)
- Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men (2017) (10)
- Contactin-1 autoimmunity Serologic, neurologic, and pathologic correlates (9)
- Selective destruction of preganglionic sympathetic nerves by antibodies to acetylcholinesterase. (1991) (9)
- Experimental Arthritis in Thymectomized Rats with an Impaired Humoral Immune Response (1973) (9)
- Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG. (2009) (9)
- The detection of autoantibody-forming cells. II. Cells in lymph nodes and central nervous system containing antibody to myelin basic protein. (1972) (9)
- Reversible Paraneoplastic Tonic Pupil with PCA-Tr IgG and Hodgkin Lymphoma (2012) (9)
- Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome (2021) (9)
- AQP4-IgG immunoprecipitation assay optimization. (2009) (9)
- Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes (2021) (8)
- Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis (2018) (8)
- Enzyme immunoassay of anti‐human acetylcholine receptor autoantibodies in patients with myasthenia gravis reveals correlation with striational autoantibodies (1993) (8)
- CHRONIC PROGRESSIVE PARANEOPLASTIC SYNDROME WITH PROMINENT BRAINSTEM AND SPINAL CORD INVOLVEMENT, ASSOCIATED WITH TYPE-2 ANTI-NEURONAL NUCLEAR ANTIBODIES (ANNA-2) AND BREAST CARCINOMA: 212 (1995) (8)
- Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis (1978) (8)
- Muscle and Neuronal Autoantibody Markers of Thymoma (2003) (8)
- Revised diagnostic criteria for neuromyelitis optica (2011) (8)
- Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders (2021) (8)
- Humoral factors in myasthenia gravis (1975) (7)
- AUTOIMMUNE CEREBELLAR DEGENERATION ASSOCIATED WITH CANCER: LOCALIZATION OF PURKINCE CYTOPLASMIC ANTIGEN BY IMMUNO-ELECTRON MICROSCOPY (1986) (7)
- Cross-talk between nervous and immune systems in response to injury. (1994) (7)
- Paraneoplastic Neurological Autoimmunity (2008) (7)
- Voltage‐Dependent Ca2+ Channels in Small Cell Carcinomas Are Blocked by Autoantibodies from Patients with Lambert‐Eaton Myasthenic Syndrome a (1988) (6)
- Autoimmune autonomic neuropathy (2002) (6)
- Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy (2016) (6)
- Calcium channel autoimmunity: Cerebellar ataxia and lambert‐eaton syndrome coexisting (2018) (6)
- Evidence for Structural Dissimilarity in the Neurotransmitter Binding Region of Purified Acetylcholine Receptors from Human Muscle and Torpedo Electric Organ (1986) (6)
- Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity (2020) (6)
- Autoantibodies in the Postural Tachycardia Syndrome (P1.272) (2015) (6)
- The detection of autoantibody-forming cells. I. An assay for plaque-forming cells to the basic protein of myelin in guinea-pigs. (1972) (6)
- Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG (2012) (6)
- ACh receptor protein drives primary and memory autoantibody responses in chimeric human-SCID mice. (2002) (6)
- Membrane array of acetylcholine receptors determines complement-dependent mononuclear phagocytosis in experimental myasthenia gravis (1984) (6)
- Autoimmune Myelopathies (2011) (5)
- Genetic variation in statin intolerance and a possible protective role for UGT1A1. (2018) (5)
- Radiometallating Antibodies and Autoantigenic Peptides (1991) (5)
- Lambert-Eaton Syndrome (2009) (5)
- Synthetic Peptide of Human Acetylcholine Receptor α‐Subunit Sequence 125‐147 (Methionine 144), a More Potent Autoantigen Than Its Norleucine 144 Analog a (1988) (5)
- Nine Residues Influence the Binding of α‐Bungarotoxin in α‐Subunit Region 185–200 of Human Muscle Acetylcholine Receptor (1993) (5)
- Complement-mediated lesion of sympathetic ganglia in vitro with acetylcholinesterase antibodies (1999) (4)
- Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults (2022) (4)
- Purkinje cell cytoplasmic antibody type 1 (anti-Yo) autoimmunity in a child with Down syndrome. (2014) (4)
- Asymptomatic lambert–eaton syndrome (2014) (4)
- Effects of Age and Sex on Aquaporin-4 Autoimmunity (S60.002) (2012) (3)
- GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin‐Associated Ataxia and Neuropathy (2020) (3)
- Oncological, Neurological, and Serological Accompaniments (2017) (3)
- Spectrum of sublytic astrocytopathy in neuromyelitis optica (2021) (3)
- DIFFERENTIATION ANTIGENS OF DEVELOPING AND REGENERATING SKELETAL MUSCLE (1978) (3)
- The association of pauciarticular juvenile arthritis and myasthenia gravis. (1991) (3)
- Lambert‐Eaton Myasthenic Syndrome: Antigenicity of Recombinant Human P/Q‐type Calcium Channel α1 Subunit Putative Ion Pore Region (Domain IV, S5‐S6) a (1998) (3)
- Autoimmune autonomic neuropathy. An immunopharmacological disease. (2002) (2)
- Acetylcholine receptor antibodies in tardive dyskinesia. (1994) (2)
- Content and release of acetylcholinesterase in skeletal muscle of rats with experimental autoimmune myasthenia gravis (1982) (2)
- Swine Influenza Vaccine and Guillain-Barré Syndrome: Lies, Damn Lies, and...-Reply (1986) (2)
- Anti‐Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1 (2022) (2)
- BRAIN TUMOR IMMUNOREACTIVITY WITH TYPE 1 AND TYPE 2 ANTI-NEURONAL NUCLEAR AUTOANTIBODES (1996) (2)
- Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes (2009) (2)
- A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG (2016) (2)
- AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor. (1985) (2)
- NMDA receptor encephalitis: late treatment also effective. (2014) (2)
- Alpha-bungarotoxin binds to human acetylcholine receptor alpha-subunit peptide 185-199 in solution and solid phase but not to peptides 125-147 and 389-409. (1990) (2)
- Animal extremists' threats to neurologic research continue (2015) (2)
- SRP‐IgG detected incidentally associates with autoimmune myopathy (2015) (2)
- IN VITRO DIFFERENTIATION OF SKELETAL MUSCLE FROM A TRITON TUMOR: DOES HUMAN NEUROECTODERM HAVE MYOGENIC POTENTIAL? (1982) (2)
- Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients. (2016) (2)
- DPPX Autoantibody: Frequency, Clinical Accompaniments and Outcomes (S40.001) (2014) (1)
- Reply to Rossi et al.: Immunohistopathological findings in neuromyelitis optica concur with immunobiological observations in vitro (2012) (1)
- 109. Signal recognition particle subunit-specific immunoglobulin G (54 and 72) biomarkers for autoimmune necrotizing or inflammatory myopathy and neoplasia (2012) (1)
- Genetic control of experimental autoimmune myasthenia gravis (eamg) in mice. Abstr. (1979) (1)
- AQP4-IgG Assays Comparison in Laboratory Clinical Serivce (S63.004) (2014) (1)
- Experimental Acetylcholinesterase Autoimmunity (1992) (1)
- Author Response. (2016) (1)
- A Small Cell Lung Carcinoma Line and Subclone Expressing Nicotinic Acetylcholine Receptors of Muscle and Neuronal Types a (1998) (1)
- Necrotizing Autoimmune Myopathy: Comparison of Clinical Features and Treatment Outcomes among Different Etiologies (S17.002) (2015) (1)
- Evidence of aquaporin involvement in human central pontine myelinolysis (2013) (1)
- Novel redistribution of myosin-containing filaments in cultured keratinocytes identified by a human monoclonal autoantibody (1989) (1)
- Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. (1999) (1)
- Advances in myasthenia gravis proceedings of the myasthenia gravis foundation medical advisory board, New york, NY, december 3, 1982 (1983) (1)
- 65 THEILERʼS MURINE ENCEPHALOMYELITIS VIRUS (TMEV) INDUCED DEMYELINATING DISEASE: EFFECT OF TREATMENT WITH MYELIN COMPONENTS (1984) (1)
- Positron Emission Tomography-Computed Tomography in Paraneoplastic Neurologic Disorders (2017) (1)
- Striational autoantibodies: Paraneoplastic antibodies associated with thymoma and myasthenia gravis (1991) (1)
- Double seropositivity for AChR and MuSK autoantibodies in myasthenia gravis (2020) (1)
- Adult-Onset Opsoclonus-Myoclonus Syndrome (P04.045) (2012) (1)
- Immunogenicity of P/Q-type calcium channel in small cell lung cancer: investigation of alpha1 subunit polyglutamine expansion. (1999) (1)
- Antigenicity of synthetic peptides 159-169 and 151-169 of Torpedo acetylcholine receptor alpha chain. (1985) (1)
- Anti-purkinje cell cytoplasmic autoantibodies in paraneoplastic cerebellar degeneration are non-species specific and of multiple immunoglobulin classes (1987) (1)
- The Stability of Solubilized Mammalian Muscle Acetylcholine Receptors During Purification by Monoclonal Immunoadsorption (1984) (1)
- The Incidence and Prevalence of Autoimmune Encephalitis and a comparison to Infectious Encephalitis: A Population-Based Study (P5.401) (2018) (0)
- Testing for N-type Voltage Gated Calcium Channel Antibody has Limited Utility in Evaluating Patients With Suspected Lambert-Eaton Myasthenic Syndrome (2022) (0)
- WS-21-4 Clinical, electrodiagnostic and serological profile of the Lambert-Eaton myasthenic Syndrome (LES) (1995) (0)
- Ma2 Autoantibody-Negative Multifocal Paraneoplastic Neurological Disorder Associated with Metastatic Testicular Cancer. (P4.049) (2015) (0)
- neuroimaging clues Paraneoplastic isolated myelopathy : Clinical course and (2011) (0)
- Paraneoplastic multifocal neuropathy with anti-CRMP5- and anti-amphiphysin antibodies and myositis preceeding recurrence of a small-cell bladder carcinoma (2005) (0)
- Synthetic peptide encompassing human acetylcholine receptor (AChR) α subunit region 125–147 with methionine at position 144 is a potent autoantigen (1987) (0)
- Immunohistopathological findings in neuromyelitis optica concur with immunobiological observations in vitro (2012) (0)
- Cellular and humoral immune responses to human muscle acetylcholine receptors (1984) (0)
- Clinical/ Immunopathological Presentations and Antigen-specific CD8+ T Cell Responses in Paraneoplastic Autoimmune KLHL11 Encephalitis (1185) (2020) (0)
- A Mathematical Analysis of Neural Autoantibody Clusters Encountered in Sera of 78,889 Patients Undergoing Comprehensive Paraneoplastic Autoantibody Evaluation (S29.006) (2013) (0)
- Medusa Head-Type Neuronal Autoantibody Inositol Triphosphate Receptor-1 (ITPR1)-IgG: Frequency, Clinical Phenotype and Cancer Associations (P5.300) (2016) (0)
- Rho GTPase Activating Protein 26 (ARHGAP26)-Igg Autoimmunity: Frequency and Clinical Associations (P3.346) (2016) (0)
- Myasthenia gravis and normal lymphocytes respectively transfer memory and primary immune responses specific for human acetylcholine receptor into severe combined immunodeficiency mice (1994) (0)
- Nine residues influence the binding of alpha-bungarotoxin in alpha-subunit region 185-200 of human muscle acetylcholine receptor. (1993) (0)
- Difficulty Climbing the Stairs (2021) (0)
- 413. Characterization of four human neuronal voltage-gated calcium channel γ subunit genes (2000) (0)
- Effects of Neuromyelitis Optica(NMO)-IgG for leukocyte transmigration at the Blood-Brain Barrier (S46.003) (2015) (0)
- Adjuvant activity for alkylamines of immune responses to ovalbumin, myelin basic protein and a tumor. (1974) (0)
- Advances in myasthenia gravis proceedings of the myasthenia gravis foundation medical advisory board, New York, NY, December 2, 1983 (1984) (0)
- 122. Voltage-gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease (2009) (0)
- Purkinje Cell Cytoplasmic Autoantibody Type 1 Accompaniments (2016) (0)
- IMMUNOTHERAPY- DEMENTIAS AND (2010) (0)
- A Systematic Clinico-Serologic Study of Recurrent Longitudinally Extensive Transverse Myelitis (rTM) and Comparison with NMO (P02.141) (2013) (0)
- An Ia.8 restricted T-cell line specific for acetylcholine receptor (1984) (0)
- PO27-TH-15 Frequency of false positive neuronal voltage-gated potassium channel antibody detection in serological evaluation for neurological autoimmunity (2009) (0)
- Caveolae-Associated Protein (cavin)-4 Autoantibodies in Immune Mediated Rippling Muscle Disease (2022) (0)
- Biology of Human Tumors Neural Autoantibody Clusters Aid Diagnosis of Cancer (2014) (0)
- CREUTZFELDT-JAKOB DISEASE (CJD) WITH N-TYPE VOL7AGE-GATED Ca2+-CHANNEL ANTIBODIES (N-VGCC Ab) MIMICKING A PARANEOPLASTIC SYNDROME (1998) (0)
- The Stiff Child (P01.051) (2013) (0)
- The Mayo Clinic Glial Autoimmunity study: Persistence of MOG-IgG seropositivity predicts relapse after ADEM in both children and adults (S13.004) (2018) (0)
- Neuronal Intermediate Filament Autoimmunity (S52.005) (2018) (0)
- 495. A protocol for an animal model for neuroimmunologic psychiatric disease (1996) (0)
- 74 INTERACTION OF AUTOANTIBODIES WITH ACETYLCHOLINE RECEPTORS IN REGENERATED POSTSYNAPTIC MEMBRANES OF MUSCLE FAILS TO SIGNAL MONONUCLEAR PHAGOCYTOSIS (1984) (0)
- Objective and Symptomatic Reversal of Autoimmune Gastrointestinal Dysmotility with Immunotherapy (P05.208) (2012) (0)
- The Role of Immunoglobulin G in Neuromyelitis Optica (2010) (0)
- The Mayo Clinic Glial Autoimmunity Study: AQP4/MOG-IgG serostatus and outcomes in 228 patients presenting with recurrent optic neuritis (S13.007) (2018) (0)
- Advances in myasthenia gravis, proceedings of the myasthenia gravis foundation medical advisory board, New York, NY, December 4, 1981 (1982) (0)
- Autoantibody (anti‐Hu) seronegativity (1994) (0)
- Daytime Polysomnography Recording in LIG1 -Related Limbic Encephalitis—Reply (2012) (0)
- Adult-Onset Autoimmune Chorea (S08.003) (2012) (0)
- Reply: Autoantibody (Anti–Hu) seronegativity (1994) (0)
- A distinctive IgG-mediated pathogenesis for primary progressive multiple sclerosis? (2023) (0)
- Neuromyelitis Optica Spectrum Disorders, Immunology of (2014) (0)
- An Autoimmune Basis for Diabetes-Related Chorea? (2016) (0)
- Hydrocephalus in Neuromyelitis Optica (P2.270) (2014) (0)
- Aquaporin-4 autoantibodies define autoimmune optic neuritis (2008) (0)
- Re: Paraneoplastic antibodies (1995) (0)
- Voltage-dependent Ca2+ influx by human small cell carcinomas (SCC) is impaired by Ig from Lambert-eaton myasthenic syndrome (LES) (1987) (0)
- Neuromuscular Disorders and Techniques : Novel Observations and Fresh Looks Faculty (2006) (0)
- Prolonged QTc Interval in Patients Seropositive for Ganglionic (α-3) Acetylcholine Receptor Autoantibody (P1.274) (2015) (0)
- Synthetic. cap alpha. subunit peptide 125-147 of human nicotinic acetylcholine receptor induces antibodies to native receptor (1986) (0)
- Characterization of inherited canine myasthenia gravis (1983) (0)
- SERA OF MICE HYPERIMMUNIZED WITH MYELIN COMPONENTS PROMOTE CNS REMYELINATION IN CHRONIC THEILERʼS VIRUS ENCEPHALOMYELITIS (1985) (0)
- Experimental autoimmune myasthenia gravis (eamg) in mice: role of ia molecule. Abstr. (1981) (0)
- ANTIGENIC PROPERTIES OF MYELIN CONSTITUENTS AND SHEATH CELLS: 82 (1979) (0)
- The Mayo Clinic Glial Autoimmunity Study: Glial autoantibody (AQP4/MOG/GFAP) serostatus in recurrent longitudinally extensive transverse myelitis (P6.409) (2018) (0)
- PO27-TH-14 Spinocerebellar atrophy, total deafness, sensory neuronopathy and a de novo neuronal cytoplasmic antibody (2009) (0)
- Comparison of Bromcresol Purple and Capillary Protein Electrophoresis for Quantification of Serum Albumin in Multiple Myeloma (2009) (0)
- Pathogenic monoclonal antibodies define 2 regions of nicotinic acetylcholine receptor (AChR) distinct from cholinergic ligand site (1980) (0)
- Evangelos Giannitsis 2* Aqp4-igg Immunoprecipitation Assay Optimization (2009) (0)
- 104. Broad clinical spectrum of voltage-gated gotassium channel autoimmunity (2009) (0)
- T cell stimulatory and myasthenogenic regions in human skeletal muscle acetylcholine receptor (AChR) α subunit (1991) (0)
- 101. Asymptomatic Lambert–Eaton myasthenic syndrome (2009) (0)
- News Items / Erratum (1972) (0)
- Marker of neuromyelitis optica (2004) (0)
- The Stiff Child (IN1-1.004) (2013) (0)
- A Case of Idiopathic Autoimmune Gastrointestinal Dysmotility: 606 (2005) (0)
- Paediatric autoimmune encephalopathies: a lot done, more to do (2012) (0)
- 315. High voltage-activated calcium channels: Review and implications for mental illness (1996) (0)
- Neuronal autoantibodies excite guinea pig myenteric neurons (2010) (0)
- Erratum: Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: Intravitreal triamcinolone acetonide therapy of four eyes (Eye (2008) 22 (1191-1193) DOI:10.1038/sj.eye.6702959) (2009) (0)
- Anti-synaptic autoimmunity: An emerging clinical entity (1991) (0)
- Prospective Evaluation of Maintenance Plasma Exchange (mPLEX) for Attack Prevention in Neuromyelitis Optica Spectrum Disorder: Preliminary Feasibility, Safety, and Efficacy Data (P5.265) (2015) (0)
- FP45-TH-05 Signal recognition particle antibodies define an autoimmune myopathy spectrum (2009) (0)
- Synthesis of an antigenic site of native acetylcholine receptor (AChR) alpha chain: Peptide α159-169 (1985) (0)
- Reply (2001) (0)
- Clinical utility of testing cerebrospinal fluid (CSF) for AQP4-IgG: A guideline to improve physician ordering of AQP4-IgG diagnostic test. (S12.003) (2016) (0)
- Antigenic requirements for induction of hyperacute EAE (1975) (0)
- Bulbar-Predominant Weakness (2021) (0)
- What Is the Frequency of “Truly” AQP4-IgG-Negative NMO and Does It Differ Phenotypically from Seropositive Disease? (P02.136) (2013) (0)
- Case Control Analysis of Glycine Receptor Autoimmunity (P5.125) (2017) (0)
- Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients (I4-4B) (2015) (0)
- Glucocorticoid Regulation of Ependymal Glia and Regenerative Potential after Spinal Cord Injury (2018) (0)
- 003 Autoimmune encephalitis antibody biomarkers: frequency, age and sex associations (2021) (0)
- Progressive Autoimmune Neuromyotonia with Low Voltage-Gated Potassium Channel-Complex IgG and CASPR2-IgG Following Remote Inflammatory Polyradiculoneuropathy (P4.019) (2015) (0)
- Letter: Experimental arthritis in thymectomized rats with an impaired humoral immune response. (1973) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vanda Alice Lennon?
Vanda Alice Lennon is affiliated with the following schools: